Elosone

Elosone

mometasone

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma

Marketer:

Taisho Pharmaceutical
Concise Prescribing Info
Contents
Mometasone furoate
Indications/Uses
Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage/Direction for Use
Cream/oint Apply a thin film to affected skin areas once daily.
Contraindications
Allergy to corticosteroids, infection at treatment site, skin atrophy, cataracts, DM, glaucoma, TB.
Special Precautions
Discontinue treatment if irritation or sensitization develops. Systemic absorption may be increased when extensive BSA are treated or during occlusive dressing. Not for ophth use. Infant & childn (long-term use).
Adverse Reactions
Rarely paresthesia, pruritus, signs of skin atrophy, burning, tingling/stinging.
ATC Classification
D07AC13 - mometasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases.
Additional Information
Exemptions granted for limited sale and supply without prescription (with effect from 31 March 2016):
As a topical preparation as a single agent not exceeding 0.1%
Indications: Symptomatic relief of inflammatory skin or scalp disorders such as dermatitis and eczema.
Maximum daily dose: Apply to the affected areas once daily
Maximum supply: 15 g for cream/ointment/gel 30 mL for topical solution
Minimum age: 18 years
Presentation/Packing
Form
Elosone cream 0.1%
Packing/Price
15 g x 1's
Form
Elosone oint 0.1%
Packing/Price
15 g x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in